Dr. Lal Path Labs Ltd. — Updates, 23-10-2024: Press Release

Dr. Lal PathLabs reported a revenue of ₹660 crore for Q2 FY 2024-25, marking a 9.8% increase from the same quarter last year. EBITDA rose 13.9% with a margin of 30.7%, and PAT grew by 18.1% with a margin of 19.8%. The company also declared a second interim dividend of ₹6 per share for FY25.